Results 131 to 140 of about 6,043 (171)
Some of the next articles are maybe not open access.

Analysis of the efficacy of the new cardiotonic agent TA-064

American Heart Journal, 1985
TA-064 is a new cardiotonic agent which is also effective orally, according to investigations conducted in Japan. We analyzed computer-assisted alterations of pressure-volume relationships serially and of indirect myocardial oxygen consumption (MVO2) estimations on line during TA-064 influence in 16 patients with congestive cardiomyopathy: left ...
J, Thormann   +5 more
openaire   +2 more sources

Use of Cardiotonic Agent (Mephentermine) in Myocardial Depression Due to Potassium

Archives of Surgery, 1959
Recent studies have demonstrated that prolonged induced cardiac arrest is followed by myocardial damage 1,2 and depressed ventricular function 3 in the dog. It has also been shown that this depression may be limited by prophylactic digitalization 4 and by hypothermia.
T, COOPER   +3 more
openaire   +2 more sources

[New cardiotonic agents].

Annales de cardiologie et d'angeiologie, 1986
The possibilities for therapy in the field of severe cardiac insufficiency have been extended in recent years by the introduction of novel agents endowed with a positive inotropic action. These substances may be arranged in two large classes: sympathomimetic agents and "non sympathomimetic--non digitalis-like" inotropic agents.
openaire   +1 more source

[Membranotropic action of cardiotonic agents and ubiquinone].

Ukrainskii biokhimicheskii zhurnal (1978), 1991
Interaction of cardiotonic drugs (strophantidine acetate, suphan, para-oxybenzoic acid) and ubiquinone with phospholipid bilayers has been studied. Exothermic effect of the reaction followed by an increase in microviscosity and hydrophobicity of the bilayer from cardiolipin, but by a decrease of the microviscosity of the bilayer from lecithin has been ...
I S, Chekman   +3 more
openaire   +1 more source

[Value and limitations of new cardiotonic agents].

Bulletin de l'Academie nationale de medecine, 1989
New cardiotonic agents are an original approach in the treatment of severe heart failure. They can be classified into two groups: --beta-adrenergic agonists which stimulate beta-adrenergic receptors and, therefore, increase cyclic AMP production and intracellular calcium concentration; --phosphodiesterase inhibitors which block the cyclic AMP ...
Y, Grosgogeat, M, Komajda
openaire   +1 more source

Inosine : a naturally occurring cardiotonic agent.

Journal de pharmacologie, 1984
For many years, Inosine was considered to be a simple metabolite of adenosine which was devoid of any cardiovascular effects. This theoretical ineffectiveness can be explained in the light of recent studies by the use of inadequate doses. In fact, higher doses of inosine, a non-toxic nucleoside, have demonstrated, experimentally, a cardiovascular ...
openaire   +1 more source

New Cardiotonic Agents

ASA Refresher Courses in Anesthesiology, 1994
openaire   +1 more source

[New cardiotonic agents].

Presse medicale (Paris, France : 1983), 1987
M, Komajda, P, Lechat, Y, Grosgogeat
openaire   +1 more source

Home - About - Disclaimer - Privacy